在恶性间皮瘤中KLHL14抗瘤作用的表征
Angelo Canciello1,2, Reyes Benot Domínguez1, Barbara Barboni2
1Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology, Department of Biology, College of Science and Technology, Temple University, Philadelphia, PA, 19122, USA.
Heliyon
|March 21, 2024
概括
凯尔奇样14 (KLHL14) 蛋白质通过抑制表皮细胞-介质细胞转变来预防恶性间皮瘤的进展. 转化生长因子β (TGF-β) 调节KLHL14,提供潜在的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 恶性间皮瘤 (MM) 是一种具有不良预后的侵袭性癌症.
- 有限的治疗选择需要识别新的分子标.
- 凯尔奇样蛋白 (KLHL) 调节细胞过程,但KLHL14的功能尚不清楚.
研究的目的:
- 为了研究KLHL14在恶性间皮瘤中的作用.
- 阐明KLHL14在MM中的作用机制.
- 探索KLHL14与转化生长因子β (TGF-β) 信号之间的关系.
主要方法:
- 细胞培养和对MM细胞中KLHL14表达的操纵.
- 评估繁殖,移动性,入侵和殖民地形成.
- 分析TGF-β对KLHL14的调节,包括合成,稳定性和局部化.
主要成果:
- KLHL14的枯竭增强了MM细胞的增殖,运动,入侵和殖民地形成.
- KLHL14通过防止上皮细胞-介质细胞过渡 (EMT) 起到抗瘤原因子作用.
- TGF-β信号积极调节KLHL14的表达,稳定性和核细胞质中转移.
结论:
- KLHL14在恶性间皮瘤中起着关键的抗瘤作用.
- KLHL14的功能与TGF-β信号通路密切相关.
- 准KLHL14或其与TGF-β的相互作用可能为MM提供新的治疗策略.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K


